CASSAVA SCIENCES INC (SAVA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SAVA currently has 48.3M outstanding shares. with moderate dilution risk from 18.1M authorized shares representing 37.4% potential dilution. The company has minimally diluted shareholders by 7.52% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 48.3M shares outstanding |
48M | 18M |
| Mar 12, 2026 |
10-K filing | 48.3M shares outstanding |
48M | 18M |
| Nov 12, 2025 |
10-Q filing | 48.3M shares outstanding |
48M | 18M |
| May 08, 2025 |
10-Q filing | 48.3M shares outstanding |
48M | 18M |
| Mar 03, 2025 |
10-K filing | 46.6M shares outstanding |
47M | 20M |
| Nov 07, 2024 |
10-Q filing | 48.0M shares outstanding |
48M | 18M |
| Aug 08, 2024 |
10-Q filing | 46.2M shares outstanding |
46M | 20M |
| May 10, 2024 |
10-Q filing | 43.0M shares outstanding |
43M | 23M |
| Feb 28, 2024 |
10-K filing | 41.9M shares outstanding |
42M | 24M |
| Nov 07, 2023 |
10-Q filing | 42.0M shares outstanding |
42M | 24M |
| Aug 03, 2023 |
10-Q filing | 41.8M shares outstanding |
42M | 25M |
| May 01, 2023 |
10-Q filing | 41.7M shares outstanding |
42M | 25M |
| Feb 28, 2023 |
10-K filing | 41.7M shares outstanding |
42M | 25M |
| Nov 22, 2022 |
8-K filing: Cassava Sciences, Inc. completed a registered direct offering of 1,666,667 shares of common stock at $30.00 per share, resulting in gross proceeds of approximately $50 million. ($50.0M proceeds) |
40M | 26M |
| Nov 07, 2022 |
10-Q filing | 40.1M shares outstanding |
40M | 26M |
| Aug 04, 2022 |
10-Q filing | 40.1M shares outstanding |
40M | 26M |
| May 05, 2022 |
10-Q filing | 40.1M shares outstanding |
40M | 26M |
| Mar 01, 2022 |
10-K filing | 40.0M shares outstanding |
40M | 26M |
| Nov 15, 2021 |
10-Q filing | 40.0M shares outstanding |
40M | 26M |
| Aug 04, 2021 |
10-Q filing | 40.0M shares outstanding |
40M | 26M |
| Apr 29, 2021 |
10-Q filing | 40.0M shares outstanding |
40M | 26M |
| Mar 23, 2021 |
10-K filing | 39.9M shares outstanding |
40M | 26M |
| Nov 09, 2020 |
10-Q filing | 25.6M shares outstanding |
26M | 41M |
| Aug 12, 2020 |
10-Q filing | 24.9M shares outstanding |
25M | 41M |
| May 06, 2020 |
10-Q filing | 24.8M shares outstanding |
25M | 42M |
| Apr 09, 2020 |
S-3/A filing: The filing is an S-3/A form for a shelf offering of up to $200,000,000 of common stock, preferred stock, depositary shares, warrants, debt securities, or units. |
22M | 45M |
| Mar 27, 2020 |
S-3 filing: Cassava Sciences files an S-3 form on 2020-03-27 to offer up to $200 million of common stock, preferred stock, depositary shares, warrants and debt securities in one or more offerings and in any combination. |
22M | 55M |
| Mar 26, 2020 |
10-K filing | 24.7M shares outstanding |
25M | 0 |